Analysis of risk factors of fungal superinfections in viral pneumonia patients: A systematic review and meta-analysis.

Hanxiang NieHongying YuQibin LinJieying ZhongWenjin SunHanxiang Nie

Published in: Immunity, inflammation and disease (2023)

Our research shows that corticosteroid treatment was an important risk factor for the development of fungal infection in patients with viral pneumonia. High APACHE II scores, tumors, and immunocompromised condition are also important risk factors of developing IPA. The diagnosis of fungal infection in viral pneumonia patients can be facilitated by early serum galactomannan (GM) testing, bronchoalveolar lavage fluid Aspergillus antigen testing, culture, and biopsy.

Keyphrases

risk factors
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
sars cov
peritoneal dialysis
respiratory failure
patient reported outcomes